SGK1 is identified and characterized as a tumor-promoting gene, and SGK1 dysregulation has been observed in several types of malignancies, including breast cancer (14), gastric cancer (15), lung cancer (16, 17), and prostate cancer (18). Here, SGK1 is linked to neoplasm.